Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WDR5 | P61964 | 1/20 | 0.66 |
| ▸ | LDHA | P00338 | 1/20 | 0.63 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.59 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.59 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.53 |
| ▸ | HPGD | P15428 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | CDC25B | P30305 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.47 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.47 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.47 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6916524 | 0.98 | WDR5 (0.63) | WDR5LDHANR4A1NR4A2NR4A3 | |
| SCHEMBL6908614 | 0.98 | WDR5 (0.63) | WDR5LDHANR4A1NR4A2NR4A3 | |
| SCHEMBL6917503 | 0.98 | WDR5 (0.63) | WDR5LDHANR4A1NR4A2NR4A3 | |
| SCHEMBL6912830 | 0.98 | WDR5 (0.63) | WDR5LDHANR4A1NR4A2NR4A3 | |
| SCHEMBL6915347 | 0.98 | WDR5 (0.63) | WDR5LDHANR4A1NR4A2NR4A3 | |
| SCHEMBL6917500 | 0.98 | WDR5 (0.63) | WDR5LDHANR4A1NR4A2NR4A3 | |
| SCHEMBL6915351 | 0.98 | WDR5 (0.63) | WDR5LDHANR4A1NR4A2NR4A3 | |
| SCHEMBL6909817 | 0.98 | WDR5 (0.63) | WDR5LDHANR4A1NR4A2NR4A3 | |
| SCHEMBL6908171 | 0.98 | WDR5 (0.63) | WDR5LDHANR4A1NR4A2NR4A3 | |
| SCHEMBL6916528 | 0.98 | WDR5 (0.63) | WDR5LDHANR4A1NR4A2NR4A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 309 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2207525-B1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT METHOD | L'ORÉAL (FR) | 2017-02-22 | — | — | EP | claimed |
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | claimed |
| US-8790625-B2 | Polycondensate, composition containing a polycondensate, method of treatment, and method of preparation | L'OREAL (FR) | 2014-07-29 | — | — | US | claimed |
| CN-101095654-B | Cosmetic or medical composition comprising a condensation polymer, the cosmetic processing method of using said composition, said condensation polymer and the method for preparing the same | OREAL | 2012-07-18 | — | — | CN | claimed |
| CN-102405039-A | Cosmetic or dermatological composition comprising a polymer containing linking groups, and cosmetic treatment method | OREAL | 2012-04-04 | — | — | CN | claimed |
| EP-1844761-B1 | Cosmetic or pharmaceutical composition comprising a condensation polymer, cosmetic treatment method employing said composition, said condensation polymer and preparation method | OREAL (FR) | 2010-05-19 | — | — | EP | claimed |
| US-20090028807-A1 | COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION | L'OREAL (FR) | 2009-01-29 | — | — | US | claimed |
| CN-101347389-A | Cosmetic or pharmaceutical composition comprising a condensation polymer, cosmetic treatment method, condensation polymer and preparation method | OREAL (FR) | 2009-01-21 | — | — | CN | claimed |
| US-20080260665-A1 | Nail varnish comprising at least one polycondensate and at least one polyoxyalkylene copolymer | L'OREAL S.A. (FR) | 2008-10-23 | — | — | US | claimed |
| US-20080152607-A1 | POLYCONDENSATE, COMPOSITION CONTAINING A POLYCONDENSATE, METHOD OF TREATMENT, AND METHOD OF PREPARATION | L'OREAL (FR) | 2008-06-26 | — | — | US | claimed |
| US-20080069786-A1 | POLYCONDENSATE, COMPOSITION, TREATMENT PROCESS, AND PREPARATION PROCESS | L'OREAL (FR) | 2008-03-20 | — | — | US | claimed |
| CN-101095654-A | Cosmetic or medical composition comprising a condensation polymer, the cosmetic processing method of using said composition, said condensation polymer and the method for preparing the same | OREAL (FR) | 2008-01-02 | — | — | CN | claimed |
| CN-101088487-A | Cosmetic or pharmaceutical composition comprising a condensation polymer, cosmetic treatment method employing said composition, said condensation polymer and preparation method | OREAL (FR) | 2007-12-19 | — | — | CN | claimed |
| US-6444782-B1 | AROMATIC POLYESTERS; ENDCAPPING | EASTMAN CHEMICAL COMPANY | 2002-09-03 | — | — | US | claimed |
| US-20260118361-A1 | FLUOROGENIC BIOCONJUGATION OF CYCLOPROPANOL-BASED FLUOROPHORES FOR BIOLOGICAL APPLICATIONS | UNIV SOUTH CAROLINA (US) | 2026-04-30 | — | — | US | disclosed |
| US-12517445-B2 | Toner comprising charge control agent | XEROX CORPORATION (US) | 2026-01-06 | — | — | US | disclosed |
| US-12429792-B2 | Toner comprising charge control agent | XEROX CORPORATION (US) | 2025-09-30 | — | — | US | disclosed |
| US-5458814-A | Ophthalmic lenses | TRANSITIONS OPTICAL, INC. (US) | 1995-10-17 | — | — | US | disclosed |
| WO-1995016215-A1 | NOVEL SUBSTITUTED NAPHTHOPYRANS | PPG INDUSTRIES, INC. (US) | 1995-06-15 | — | — | WO | disclosed |
| US-5204364-A | Selective inhibition of thromboxane A2; anticholesterol agents treating nephrosis, hyperlipidemia | FARMITALIA CARLO ERBA, S.R.L. (IT) | 1993-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260118361-A1 | FLUOROGENIC BIOCONJUGATION OF CYCLOPROPANOL-BASED FLUOROPHORES FOR BIOLOGICAL APPLICATIONS | QSOX1, CBR1, CBR3 | WDR5 4882/4885LDHA 4821/4885NR4A1 2214/4885 |
| US-20080152607-A1 | POLYCONDENSATE, COMPOSITION CONTAINING A POLYCONDENSATE, METHOD OF TREATMENT, AND METHOD OF PREPARATION | PCCA, PAH, CUTA | WDR5 1313/4885LDHA 828/4885NR4A1 3607/4885 |
| US-20080260665-A1 | Nail varnish comprising at least one polycondensate and at least one polyoxyalkylene copolymer | POLR1C, PIK3C3, PCNA | WDR5 1945/4885LDHA 3102/4885NR4A1 2596/4885 |
| US-20090028807-A1 | COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION | CUTA, SYMPK, TPRKB | WDR5 1261/4885LDHA 2299/4885NR4A1 4625/4885 |
| US-20080069786-A1 | POLYCONDENSATE, COMPOSITION, TREATMENT PROCESS, AND PREPARATION PROCESS | POLR1C, PIK3C3, SUV39H2 | WDR5 364/4885LDHA 3356/4885NR4A1 2468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.